54 772 Pill - white round
Generic Name: dihydrotachysterol
Pill with imprint 54 772 is White, Round and has been identified as DHT 0.4 mg. It is supplied by Roxane Laboratories, Inc.
DHT is used in the treatment of Hypoparathyroidism; Osteoporosis; Hypocalcemia; Hypophosphatemia; Renal Osteodystrophy and belongs to the drug class vitamins. Risk cannot be ruled out during pregnancy. DHT 0.4 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 54 772

DHT
- Generic Name
- dihydrotachysterol
- Imprint
- 54 772
- Strength
- 0.4 mg
- Color
- White
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Vitamins
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Roxane Laboratories, Inc.
- National Drug Code (NDC)
- 00054-4191 (Discontinued)
See also:
Prolia
Prolia (denosumab) is an injection that is administered subcutaneously (under the skin) once every ...
Fosamax
Fosamax (alendronate) is used to treat or prevent postmenopausal osteoporosis and steroid-induced ...
Evenity
Evenity (romosozumab) injection is used to treat osteoporosis in postmenopausal women to reduce the ...
Premarin
Premarin is used to treat symptoms of menopause such as hot flashes, and vaginal dryness. Learn ...
Reclast
Reclast (zoledronic acid) is used to treat osteoporosis in women after menopause and also to treat ...
Zometa
Zometa is used to treat high blood levels of calcium caused by cancer and multiple myeloma. Learn ...
Xgeva
Xgeva prevents bone fractures and other skeletal conditions in people with multiple myeloma, and is ...
Atelvia
Atelvia (risedronate) is used to treat osteoporosis in women after menopause. Includes Atelvia side ...
Boniva
Boniva (ibandronate) is used to treat or prevent osteoporosis in women after menopause. Includes ...
More about DHT (dihydrotachysterol)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: vitamins
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.